Sophrosyne Capital’s Sophiris Bio, Inc. SPHS Stock Holding History

Sophrosyne Capital’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-93,900	Closed	-$211K	–	78
2014 Q2	$211K	Hold	93,900	–	–	0.21%	46
2014 Q1	$314K	Buy	+93,900	New	+$368K	0.28%	54

Other funds holding SPHS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Sophrosyne Capital's SPHS Position: Q3 2014 in Review

Sophrosyne Capital sold out of Sophiris Bio, Inc. (SPHS) in Q3 2014, closing a stake of 93,900 shares — an estimated $211K sold.

Sophrosyne Capital first reported a position in SPHS in Q1 2014 and held it in 2 quarters. The position peaked at $314K in Q1 2014. 21 funds tracked by Wall St. Rank hold SPHS as of Q3 2014.

Sophrosyne Capital reported no remaining Sophiris Bio, Inc. position as of Q3 2014 after selling out during the quarter.
Sophrosyne Capital sold 93,900 Sophiris Bio, Inc. shares in Q3 2014, an estimated $211K.
Sophrosyne Capital first reported a position in Sophiris Bio, Inc. in Q1 2014 and held it in 2 quarters.
Sophrosyne Capital's Sophiris Bio, Inc. position peaked at $314K in Q1 2014.
21 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2014.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.